Flash Report /

Three stocks exposed to a possible monkeypox outbreak

  • Monkeypox, a rare disease, has emerged in Europe and the US

  • It is unclear whether this outbreak is serious

  • We alert investors to three pharmaceutical stocks – Siga Technologies, Bavarian Nordic, and Emergent Biosolutions

Three stocks exposed to a possible monkeypox outbreak
Nirgunan Tiruchelvam
Nirgunan Tiruchelvam

Head of Consumers Equity Research

Tellimer Research
24 May 2022
Published by

What is monkeypox?

As Covid recedes, another virus has reared its head. Monkeypox is an extremely rare disease outside of Africa. It is related to smallpox, which was wiped out in the 1970s through worldwide vaccination efforts.

Monkeypox is endemic to West and Central Africa, but only occasionally found in Europe and the US.

What are its symptoms?

Monkeypox can spread through contact with bodily fluids containing the virus. It is not transmitted through the air like Covid, therefore it spreads far more slowly.

The extent of the spread

There has been a larger outbreak of monkeypox than normal in the Democratic Republic of Congo (DRC). Over 1,287 cases have been reported in DRC this year, including 57 fatalities.

Last week, a confirmed case of monkeypox was reported in the US. There were two monkeypox cases in the US in 2021, but they were from people who had travelled to Nigeria.

There have been a number of cases in countries across Europe, with the UK and Spain having the most incidents.

Monkeypox Cases: 24 May

Three stocks exposed to the monkeypox outbreak

The scale of the monkeypox outbreak remains uncertain. There are currently less than a few hundred cases according to the WHO.

For investors seeking exposure, we highlight three drug companies that make monkeypox vaccines and anti-virals. They have risen sharply on the news.

Company Description